Knockdown of the suppressor phosphatase and tensin homolog (PTEN, a negative regulator of AKT), increased PI3K and AKT phosphorylation in ER(+) breast cancer cell lines, resulting in hormone-independent growth and resistance to tamoxifen and fulvestrant [123,124]. The gene discussed is PTEN; the disease is breast carcinoma.